The MLL gene and translocations involving chromosomal band 11q23 in acute leukemia

Anticancer Research

Volumn 25, Issue 3 B, 2005, Pages 1931-1944

  De Braekeleer, Marc ^a,b   Morel, Frédéric ^a,b   Le Bris, Marie Josée ^b   Herry, Angèle ^a   Douet Guilbert, Nathalie ^a,b  

^a FACULTÉ DE MÉDECINE ET DES SCIENCES DE LA SANTÉ   (France)

^b CHU MORVAN   (France)

Author keywords

Acute leukemia; Chromosomal band 11q23; MLL gene

Indexed keywords

DNA; HYBRID PROTEIN;

ACUTE LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ACUTE MYELOBLASTIC LEUKEMIA; CELL DIFFERENTIATION; CHROMOSOME 11Q; CHROMOSOME REARRANGEMENT; CHROMOSOME TRANSLOCATION 11; DOWN REGULATION; GENE; GENE ACTIVATION; GENE CLUSTER; GENE DISRUPTION; GENE EXPRESSION REGULATION; GENE FREQUENCY; GENE FUNCTION; GENE FUSION; GENE IDENTIFICATION; GENE LOCATION; GENE STRUCTURE; HEMATOLOGIC MALIGNANCY; HEMATOPOIETIC STEM CELL; HUMAN; LEUKEMOGENESIS; LYMPHOID CELL; MLL GENE; MOLECULAR CLONING; MYELOID PROGENITOR CELL; NONHUMAN; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; PROGNOSIS; PROTEIN FUNCTION; RECIPROCAL CHROMOSOME TRANSLOCATION; REVIEW;

CHROMOSOME BANDING; CHROMOSOMES, HUMAN, PAIR 11; DNA-BINDING PROTEINS; HUMANS; LEUKEMIA, LYMPHOCYTIC, ACUTE; LEUKEMIA, MYELOCYTIC, ACUTE; MYELOID-LYMPHOID LEUKEMIA PROTEIN; PROTO-ONCOGENES; TRANSCRIPTION FACTORS; TRANSLOCATION, GENETIC;

EID: 21344472782     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (85)

1. Cleary ML: Oncogenic conversion of transcription factors by chromosomal translocations. Cell 66: 619-622, 1991.
2. Nichols J and Nimer SD: Transcription factors, translocations, and leukemia. Blood 80: 2953-2963, 1992.
3. Tkachuk DC, Kohler S and Cleary ML: Involvement of a homolog of Drosophila trithorax by 11q23 chromosomal translocations in acute leukemias. Cell 71: 691-700, 1992.
4. Gu Y, Nakamura T, Alder H, Prasad R, Canaani O, Cimino G, Croce CM and Canaani E: The t(4;11) chromosome translocation of human acute leukemias fuses the ALL-1 gene, related to Drosophilia trithorax, to the AF-4 gene. Cell 71: 701-708, 1992.
5. Djabali M, Selleri L, Parry P, Bower M, Young BD and Evans GA: A trithorax-like gene is interrupted by chromosome 11q23 translocations in acute leukemias. Nature Genet 2: 113-118, 1992.
6. Ziemin-van der Poel S, McCabe NR, Gill HJ, Espinosa RI, Patel Y, Harden A, Rubinelli P, Smith SD, LeBeau MM, Rowley JD and Diaz MO: Identification of a gene, MLL, that spans the breakpoint in 11q23 translocations associated with human leukemias. Proc Natl Acad Sci USA 88: 10735-10739, 1991.
7. McCabe NR, Burnett RC, Gill HJ, Thirman MJ, Mbangkollo D, Kipiniak M, van Meile E, Ziemin-van der Poel S, Rowley JD and Diaz MO: Cloning of cDNAs of the MLL gene that detect DNA rearrangements and altered RNA transcripts in human leukemic cells with 11q23 translocations. Proc Natl Acad Sci USA 89: 11794-11798, 1992.
8. Cimino G, Moir DT, Canaani O, Williams K, Grist WM, Katzav S, Cannizzaro L, Lange B, Nowell PC, Croce CM and Canaani E: Cloning of ALL-1, the locus involved in leukemias with the t(4;11)(q21;q23), t(9;11)(p22;q23), and t(11;19)(q23;p13) chromosome translocations. Cancer Res 57: 6712-6714, 1991.
9. Mitelman F, Johansson B and Mertens F: Mitelman database of chromosome aberrations in cancer. http://cgapncinih gov/Chromosomes/Mitelman 2003.
10. Watanabe N, Kobayashi H, Ochiji O, Yoshida MA, Kikuta A, Komada Y, Sekine I, Ishida Y, Horiukoshi Y, Tsunematsu Y, Yano M, Nakadate H and Kaneko Y: Cryptic insertion and translocation or nondividing leukemic cells disclosed by FISH analysis in infant acute leukemia with discrepant molecular and cytogenetic findings. Leukemia 17: 876-882, 2003.
11. Caligiuri MA, Schichman SA, Strout MP, Mrozek K, Baer MR, Frankel SR, Barcos M, Herzig GP, Croce CM and Bloomfield CD: Molecular rearrangement of the ALL-1 gene in acute myeloid leukemia without cytogenetic evidence of 11q23 chromosomal translocations. Cancer Res 54: 370-373, 1994.
12. Schnittger S, Kinkelin U, Schoch C, Heinecke A, Haase D, Haferlach T, Buchner T, Wormann B, Hiddemann W and Griesinger F: Screening for MLL tandem duplication in 387 unselected patients with AML identify a prognostically unfavorable subset of AML. Leukemia 14: 796-804, 2000.
13. + translocation in leukaemia. Br J Haematol 121: 952-959, 2003.
14. Schoch C, Schnittger S, Klaus M, Kern W, Hiddemann W and Haferlach T: AML with 11q23/MLL abnormalities as defined by the WHO classification: incidence, partner chromosomes, FAB subtype, age distribution, and prognostic impact in an unselected series of 1897 cytogenetically analyzed AML cases. Blood 102: 2395-2402, 2003.
15. DiMartino JF and Cleary ML: MLL rearrangements in haematological malignancies: lessons from clinical and biological studies. Br J Haematol 106: 614-626, 1999.
16. Ibrahim S, Estey EH, Pierce S, Glassman A, Keating M, O'Brien S, Kantarjian HM and Albitar M: 11q23 abnormalities in patients with acute myelogenous leukemia and myelodysplastic syndrome as detected by molecular and cytogenetic analyses. Am J Clin Pathol 114: 793-797, 2000.
17. Giugliano E, Rege Cambrin G, Scaravaglio P, Wlodarska I, Emanuel B, Stul M, Serra A, Tonso A, Pini M, Saglio G and Hagemeijer A: Two new translocations involving the 11q23 region map outside the MLL locus in myeloid leukemias. Haematologica 87: 1014-1020, 2002.
18. Secker-Walker LM and on behalf of the European 11q23 Workshop participants: General report on the European Union Concerted Action Workshop on 11q23, London, UK, May 1997. Leukemia 12: 776-778, 1998.
19. Bloomfield CD, Archer KJ, Mrozek K, Lillington DM, Kaneko Y, Head DR, Dal Cin P and Raimondi SC: 11q23 balanced chromosome aberrations in treatment-related myelodysplastic syndromes and acute leukemia: report from an international workshop. Genes Chromosomes Cancer 33: 362-378, 2002.
20. Douet-Guilbert N, Morel F, Le Bris MJ, Sassolas B, Giroux JD and De Braekeleer M: Rearrangement of MLL in a patient with congenital acute monoblastic leukemia and granulocytic sarcoma associated with a t(1;11)(p36;q23) translocation. Leukemia Lymphoma 46: 143-146, 2005.
21. Douet-Guilbert N, Morel F, Le Bris MJ, Herry A, Morice P, Bourquard P, Banzakour S, Le Calvez G, Marion V, Berthou C and De Braekeleer M: Rearrangement of the MLL gene in acute myeloblastic leukemia: report of two rare translocations. Cancer Genet Cytogenet 157: 169-174, 2005.
22. Butler LH, Slany R, Cui X, Cleary ML and Mason DY: The HRX proto-oncogene product is widely expressed in human tissues and localizes to nuclear structures. Blood 89: 3361-3370, 1997.
23. Rasio D, Schichman SA, Negrini M, Canaani E and Croce CM: Complete exon structure of the ALL1 gene. Cancer Res 56: 1766-1769, 1996.
24. Nilson I, Lochner K, Siegler G, Greil J, Beck JD, Fey GH and Marschalek R: Exon/intron structure of the human ALL-1 (MLL) gene involved in translocations to chromosomal region 11q23 and acute leukaemias. Br J Haematol 93: 966-972, 1996.
25. Marschalek R, Nilson I, Lochner K, Greim R, Siegler G, Greil J, Beck JD and Fey GH: The structure of the human ALL-1/MLL/HRX gene. Leukemia Lymphoma 27: 417-428, 1997.
26. Xia ZB, Anderson M, Diaz MO and Zeleknik-Le NJ: MLL repression domain interacts with histone deacetylases, the polycomb group proteins HPC2 and BMI-1, and the corepressor C-terminal-binding protein. Proc Natl Acad Sci USA 100: 8342-8347, 2003.
27. Biondi A, Cimino G, Pieters R and Pui CH: Biological and therapeutic aspects of infant leukemia. Blood 96: 24-33, 2000.
28. Milne TA, Briggs SD, Brock HW, Martin ME, Gibbs D, Allis CD and Hess JL: MLL targets SET domain methyltransferase activity to Hox gene promoters. Mol Cell 10: 1107-1117, 2002.
29. Nakamura T, Mori T, Tada S, Krajewski W, Rozovskaia T, Wassell R, Dubois G, Mazo A, Croce CM and Canaani E: ALL-1 is a histone methyltransferase that assembles a supercomplex of proteins involved in transcriptional regulation. Mol Cell 10: 1119-1128, 2002.
30. Ayton PM and Cleary ML: Molecular mechanisms of leukemogenesis mediated by MLL fusion proteins. Oncogene 20: 5695-5707, 2001.
31. Simon JA and Tamkun JW: Programming off and on states in chromatin: mechanisms of Polycomb and trithorax group complexes. Curr Opin Genetics Develop 12: 210-218, 2002.
32. Petruk S, Sedkov Y, Smith S, Tillib S, Kraevski V, Nakamura T, Canaani E, Croce CM and Mazo A: Trithorax and dCBP acting in a complex to maintain expression of a homeotic gene. Science 294: 1331-1334, 2001.
33. Yu BD, Hanson RD, Hess JL, Horning SE and Korsmeyer SJ: MLL, a mammalian trithorax-group gene, functions as a transcriptional maintenance factor in morphogenesis. Proc Natl Acad Sci USA 95: 10632-10636, 1998.
34. Hess JL, Yu BD, Li B, Hanson R and Korsmeyer SJ: Defects in yolk sac hematopoiesis in MLL-null embryos. Blood 90: 1799-1806, 1997.
35. Corral J, Lavenir I, Impey H, Warren AJ, Forster A, Larson TA, Bell S, McKenzie AN, King G and Rabbitts TH: An MLL-AF9 fusion gene made by homologous recombination causes acute leukemia in chimeric mice: a method to create fusion oncogenes. Cell 85: 853-861, 1996.
36. Helgason CD, Sauvageau G, Lawrence HJ, Largman C and Humphries RK: Overexpression of HOXB4 enhances the hematopoietic potential of embryonic stem cells differentiated in vitro. Blood 87: 2740-2749, 1996.
37. + subpopulations of human bone marrow cells. Proc Natl Acad Sci USA 91: 12223-12227, 1994.
38. Lawrence HJ, Sauvageau G, Humphries RK and Largman C: The role of HOX homeobox genes in normal and leukemic hematopoiesis. Stem Cells 14: 281-291, 1996.
39. Ayton PM and Cleary ML: Transformation of myeloid progenitors by MLL oncoproteins is dependent on Hoxa7 and Hoxa9. Genes Develop 17: 2298-2307, 2003.
40. Douet-Guilbert N, Arnaud B, Morel F, Le Bris MJ and De Braekeleer M: Cryptic 5' MLL gene insertion in an X chromosome in acute myeloblastic leukemia. Cancer Genet Cytogenet 157: 178-180, 2005.
41. Gu Y, Alder H, Nakamura T, Schichman SA, Prasad R, Canaani O, Saito H, Croce CM and Canaani E: Sequence analysis of the breakpoint cluster region in the ALL-1 gene involved in acute leukemia. Cancer Res 54: 2326-2330, 1994.
42. Rowley JD: The critical role of chromosome translocations in human leukemias. Ann Rev Genet 32: 495-519, 1998.
43. Marschalek R, Greil J, Lochner K, Nilson I, Siegler G, Zweckbronner I, Beck JD and Fey GH: Molecular analysis of the chromosomal breakpoint and fusion transcripts in the acute lymphoblastic SEM cell line with chromosomal translocation t(4;11). Br J Haematol 90: 308-320, 1995.
44. Strissel Broeker PL, Gill Super H, Thirman MJ, Pomykala H, Yonebayashi Y, Tanabe S, Zeleknik-Le N and Rowley JD: Distribution of 11q23 breakpoints within the MLL breakpoint cluster region in de novo acute leukemia and in treatment-related acute myeloid leukemia: correlation with scaffold attachment regions and topoisomerase II consensus binding sites. Blood 87: 1912-1922, 1996.
45. Echlin-Bell DR, Smith LL, Li L, Strissel PL, Strick R, Gupta V, Banerjee J, Larson R, Relling MV, Raimondi SC, Hayashi Y, Taki T, Zeleznik-Le N and Rowley JD: Polymorphisms in the MLL breakpoint cluster region (BCR). Hum Genet 113: 80-91, 2003.
46. Cimino G, Rapanotti MC, Biondi A, Elia L, Lo Coco F, Price C, Rossi V, Rivolta A, Canaani E, Croce CM, Mandelli F and Greaves M: Infant acute leukemias show the same biased distribution of ALL1 gene breaks as topoisomerase II related secondary acute leukemias. Cancer Res 57: 2879-2883, 1997.
47. Gill Super HJ, MacCabe NR, Thirman MJ, Larson RA, Le Beau MM, Pedersen-Bjergaard J, Philip P, Diaz MO and Rowley JD: Rearrangements of the MLL in therapy-related acute myeloid leukemia in patients previously treated with agents targeting DNA-topoisomerase II. Blood 82: 3705-3711, 1993.
48. Hunger SP, Tkachuk DC, Amylon MD, Link MP, Carroll AJ, Welborn JL, Willman CL and Cleary ML: HRX involvement in de novo and secondary leukemias with diverse chromosome 11q23 abnormalities. Blood 81: 3197-3203, 1993.
49. Ross W, Rowe T, Glisson B, Yalowich J and Liu L: Role of topoisomerase II in mediating epipodophyllotoxin-induced DNA cleavage. Cancer Res 44: 5857-5860, 1984.
50. Dassonneville L and Bailly C: Translocations chromosomiques et leucémies induites par les médicaments anticancéreux inhibiteurs de la topo-isomérase II. Bull Cancer 85: 254-261, 1998.
51. Strick R, Strissel PL, Borgers S, Smith SL and Rowley JD: Dietary bioflavonoids induce cleavage in the MLL gene and may contribute to infant leukemia. Proc Natl Acad Sci USA 97: 4790-4795, 2000.
52. Ross JA: Dietary bioflavonoids and the MLL gene: a pathway to infant leukemia. Proc Natl Acad Sci USA 97: 4411-4413, 2000.
53. Cimino G, Rapanotti MC, Sprovieri T and Elia L: ALL1 gene alterations in acute leukemia: biological and clinical aspects. Haematologica 83: 350-357, 1998.
54. Ross JA, Davies SM, Potter JD and Robison LL: Epidemiology of childhood leukemia, with a focus on infants. Epidem Rev 16: 243-272, 1994.
55. Zeleznik-Le NJ, Harden AM and Rowley JD: 11q23 translocations split the "AT-hook" cruciform DNA-binding region and the transcriptional repression domain from the activation domain of the mixed-lineage leukemia (MLL) gene. Proc Natl Acad Sci USA 91: 10610-10614, 1994.
56. Rubnitz JE, Behm FG and Downing JR: 11q23 rearrangements in acute leukemia. Leukemia 10: 74-82, 1996.
57. Prasad R, Leshkowitz D, Gu Y, Alder H, Nakamura T, Saito H, Huebner K, Berger R, Croce CM and Canaani E: Leucine-zipper dimerization motif encoded by the AF17 gene fused to ALL-1 (MLL) in acute leukemia. Proc Natl Acad Sci USA 91: 8107-8111, 1994.
58. Hashii Y, Kim JY, Sawada A, Tokimasa S, Hiroyuki F, Ohta H, Makiko K, Takihara Y, Ozono K and Hara J: A novel partner gene CIP29 containing a SAP domain with MLL identified in infantile myelomonocytic leukemia. Leukemia 18: 1546-1548, 2004.
59. Sano K: Structure of AF3p21, a new member of mixed lineage leukemia (MLL) fusion partner proteins-implication for MLL-induced leukemogenesis. Leukemia Lymphoma 42: 595-602, 2001.
60. Chaplin T, Bernard O, Beverloo HB, Saha V, Hagemeijer A, Berger R and Young BD: The t(10;11) translocation in acute myeloid leukemia (M5) consistently fuses the leucine zipper motif of AF10 onto the HRX gene. Blood 86: 2073-2076, 1995.
61. DiMartino JF, Ayton PM, Chen EH, Naftzger CC, Young BD and Cleary ML: The AF10 leucine zipper is required for leukemic transformation of myeloid progenitors by MLL-AF10. Blood 99: 3780-3785, 2002.
62. Linder B, Newman R, Jones LK, Debernardi S, Young BD, Freemont P, Verrijzer CP and Saha V: Biochemical analyses of the AF10 protein: the extended LAP/PHD-finger mediates oligomerisation. J Mol Biol 299: 369-378, 2000.
63. Saha V, Chaplin T, Gregorini A, Ayton P and Young BD: The leukemia-associated-protein (LAP) domain, a cysteine-rich motif, is present in a wide range of proteins, including MLL, AF10, and MLLT6 proteins. Proc Natl Acad Sci USA 92: 9737-9741, 1995.
64. Armstrong SA, Staunton JE, Silverman LB, Pieters R, den Boer ML, Minden MD, Sallan SE, Lander ES, Golub TR and Korsmeyer SJ: MLL translocations specify a distinct gene expression profile that distinguishes a unique leukemia. Nature Genet 30: 41-47, 2002.
65. Thirman MJ, Gill HJ, Burnett RC, Mbangkollo D, McCabe NR, Kobayashi H, Ziemin-van der Poel S, Kaneko Y, Morgan R, Sandberg AA, Chaganti RSK, Larson RA, Le Beau MM, Diaz MO and Rowley JD: Rearrangement of the MLL gene in acute lymphoblastic and acute myeloid leukemias with 11q23 chromosomal translocations. N Engl J Med 329: 909-914, 1993.
66. Collins F and Rabbitts TH: The promiscuous MLL gene links chromosomal translocations to cellular differentiation and tumour tropism. Trends Mol Med 8: 436-442, 2002.
67. Grimwade D: The clinical significance of cytogenetic abnormalities in acute myeloid leukaemia. Best Pract Res Clin Haematol 14: 497-529, 2001.
68. Rowley JD: The role of chromosome translocations in leukemogenesis. Semin Hematol 36: 59-72, 1999.
69. Rowley JD: Molecular genetics in acute leukemia. Leukemia 14: 513-517, 2000.
70. Lavau C, Szilvassy SJ, Slany R and Cleary ML: Immortalization and leukemic transformation of a myelomonocytic precursor by retrovirally transduced HRX-ENL. EMBO J 16: 4226-4237, 1997.
71. Dobson CL, Warren AJ, Pannell R, Forster A, Lavenir I, Corral J, Smith AJH and Rabbitts TH: The MLL-AF9 gene fusion in mice controls myeloproliferation and specifies acute myeloid leukemogenesis. EMBO J 18: 3564-3574, 1999.
72. DiMartino JF, Miller T, Ayton PM, Landewe T, Hess JL, Cleary ML and Shilatifard A: A carboxy-terminal domain of ELL is required and sufficient for immortalization of myeloid progenitors by MLL-ELL. Blood 96: 3887-3893, 2000.
73. Martin ME, Milne TA, Bloyer S, Galoian K, Shen W, Gibbs D, Brock HW, Slany R and Hess JL: Dimerization of MLL fusion proteins immortalizes hematopoietic cells. Cancer Cell 4: 197-207, 2003.
74. Ferrando AA, Armstrong SA, Neuberg DS, Sallan SE, Silverman LB, Korsmeyer SJ and Look AT: Gene expression signatures in MLL-rearranged T-lineage and B-presursor acute leukemias: dominance of HOX dysregulation. Blood 702: 262-268, 2003.
75. Poppe B, Vandesompele J, Schoch C, Lindvall C, Mrozek K, Bloomfield CD, Beverloo HB, Michaux L, Dastugue N, Kerens C, Yigit N, de Paepe A, Hagemeijer A and Speleman F: Expression analyses identify MLL as a prominent target of 11q23 amplification and support an etiologic role for MLL gain of function in myeloid malignancies. Blood 103: 229-235, 2004.
76. Debernardi S, Lillington DM, Chaplin T, Tomlinson S, Amess J, Rohatiner A, Lister TA and Young BD: Genome-wide analysis of acute myeloid leukemia with normal karyotype reveals a unique pattern of homeobox gene expression distinct from those with translocation-mediated fusion events. Genes Chromosomes Cancer 37: 149-158,2003.
77. Alcalay M, Orleth A, Sebastiani C, Meani N, Chiaradonna F, Casciari C, Sciurpa MT, Gelmetti V, Riganelli D, Minucci S, Fagioli M and Pelicci PG: Common themes in the pathogenesis of acute myeloid leukemia. Oncogene 20: 5680-5694, 2001.
78. Taki T, Sako M, Tsuchida M and Hayashi Y: The t(11;16)(q23;p13) translocation in myelodysplastic syndrome fuses the MLL gene to the CBP gene. Blood 89: 3945-3950, 1997.
79. Ida K, Kitabayashi I, Taki T, Taniwaki M, Noro K, Yamamoto M, Ohki M and Hayashi Y: Adenoviral E1A-associated protein p300 is involved in acute myeloid leukemia with t(11;22)(q23;q13). Blood 90: 4699-4704, 1997.
80. Fu JF, Hsu JJ, Tang TC and Shih LY: Identification of CBL, a proto-oncogene at 11q23.3, as a novel MLL fusion partner in a patient with de novo acute myeloid leukemia. Genes Chromosomes Cancer 37: 214-219, 2003.
81. Daser A and Rabbitts TH: Extending the repertoire of the mixed-lineage leukemia gene MLL in leukemogenesis. Genes Develop 18: 965-974, 2004.
82. Weissman IL, Anderson DJ and Gage F: Stem and progenitor cells: origins, phenotypes, lineage commitments and transdifferentiations. Annu Rev Cell Dev Biol 17: 387-403, 2001.
83. Bonnet D and Dick JE: Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med 3: 730-737, 1997.
84. Miyamoto T, Weissman IL and Akashi K: AML1/ETO-expressing nonleukemic stem cells in acute myelogenous leukemia with 8;21 chromosomal translocation. Proc Natl Acad Sci USA 97: 7521-7526, 2000.
85. Armstrong SA, Golub TR and Korsmeyer SJ: MLL-rearranged leukemias: insights from gene expression profiling. Semin Hematol 40: 268-273, 2003.